Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel: The Memorial Sloan-Kettering Cancer Center experience
- 31 December 2003
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 91 (3) , 584-590
- https://doi.org/10.1016/j.ygyno.2003.08.017
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experienceCancer, 2010
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian CancerJournal of Clinical Oncology, 2002
- Second-Line Therapy for Potentially Platinum-Sensitive Recurrent Ovarian Cancer: What Is Optimal Treatment?Gynecologic Oncology, 2001
- Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian CancerGynecologic Oncology, 2001
- A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer.Oncology Reports, 2001
- Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapyEuropean Journal Of Cancer, 1999
- Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian CancerGynecologic Oncology, 1996
- Salvage Chemotherapy for Epithelial Ovarian CarcinomaGynecologic Oncology, 1994
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990